CD163 and osteosarcoma: For instance, Gomez and his colleagues (45) proposed a systematic analysis of CD68, CD163, CD8, PD1 and PDL-1 expression performed in osteosarcoma biopsies to stratify patients regarding their respective TME and suggested a therapeutic strategy targeting macrophages and other immunological factors.